Management of hereditary angioedema: 2010 Canadian approach

C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowen, Tom, Brosz, John, Brosz, Kristylea, Hebert, Jacques, Ritchie, Bruce
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921103/
https://www.ncbi.nlm.nih.gov/pubmed/20667123
http://dx.doi.org/10.1186/1710-1492-6-20
_version_ 1782185347895001088
author Bowen, Tom
Brosz, John
Brosz, Kristylea
Hebert, Jacques
Ritchie, Bruce
author_facet Bowen, Tom
Brosz, John
Brosz, Kristylea
Hebert, Jacques
Ritchie, Bruce
author_sort Bowen, Tom
collection PubMed
description C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http://www.haecanada.com to advance care of patients with this disorder in Canada. We here present a review of management of HAE in Canada.
format Text
id pubmed-2921103
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29211032010-08-13 Management of hereditary angioedema: 2010 Canadian approach Bowen, Tom Brosz, John Brosz, Kristylea Hebert, Jacques Ritchie, Bruce Allergy Asthma Clin Immunol Research C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http://www.haecanada.com to advance care of patients with this disorder in Canada. We here present a review of management of HAE in Canada. BioMed Central 2010-07-28 /pmc/articles/PMC2921103/ /pubmed/20667123 http://dx.doi.org/10.1186/1710-1492-6-20 Text en Copyright ©2010 Bowen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bowen, Tom
Brosz, John
Brosz, Kristylea
Hebert, Jacques
Ritchie, Bruce
Management of hereditary angioedema: 2010 Canadian approach
title Management of hereditary angioedema: 2010 Canadian approach
title_full Management of hereditary angioedema: 2010 Canadian approach
title_fullStr Management of hereditary angioedema: 2010 Canadian approach
title_full_unstemmed Management of hereditary angioedema: 2010 Canadian approach
title_short Management of hereditary angioedema: 2010 Canadian approach
title_sort management of hereditary angioedema: 2010 canadian approach
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921103/
https://www.ncbi.nlm.nih.gov/pubmed/20667123
http://dx.doi.org/10.1186/1710-1492-6-20
work_keys_str_mv AT bowentom managementofhereditaryangioedema2010canadianapproach
AT broszjohn managementofhereditaryangioedema2010canadianapproach
AT broszkristylea managementofhereditaryangioedema2010canadianapproach
AT hebertjacques managementofhereditaryangioedema2010canadianapproach
AT ritchiebruce managementofhereditaryangioedema2010canadianapproach

Ejemplares similares